Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
-0.66%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sunday 22 April 2012 11:44 pm  |  Updated:  Thursday 30 May 2019 10:06 am

Chinese in £1bn talks to gobble up Weetabix

By: KCS-content

Add as a preferred source on Google

THE OWNER of Weetabix, one of Britain’s biggest breakfast cereal producers, is in talks with a Chinese company about a possible sale of the business.

Bright Foods, Shanghai’s government-owned food-maker, is in discussions with Weetabix-owner Lion Capital about a bid believed to be in the region of £1bn.

Such a price-tag would be a 70 per cent return for Lion Capital, which bought the company in 2003 for £642m.

But Bright Foods could face competition from other interested parties from China and the UK, with recently listed cash shell Justice Holdings believed to have looked at a bid.

If Weetabix, which also makes Ready brek and Alpen muesli, were sold to a Chinese buyer, it could draw comparisons with US-owned Cadbury’s as another example of a home-grown British food-maker sold to a foreign buyer. Weetabix employs 2,000 people and is based in Northamptonshire.

WEETABIX BESTSELLERS
Weetabix was first produced in 1932 and is now sold in 80 countries.

In 1991, Weetabix acquired Ready brek, the instant porridge cereal.

Alpen muesli was launched in 1971, followed by the launch of Alpen bars in 2002.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NULL

Trending Articles

  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

  • Analysis: What would Todd Boehly and Mark Walter stake sales mean for Chelsea?

  • We take a food and drink Odyssey through the Square Mile

  • Paramount-Warner Bros deal faces ‘sufficient competition’, says CMA

  • Watchdog takes aim at lawyers blaming juniors for AI blunders

More from Morning Wire

  • Government urged to refuse £1bn British Steel repayment to Chinese former owner 

    Politics
    Labour's Jonathan Reynolds unveiled the industrial strategy in June.
  • Boutique London advisory firm lands £8m funding amid M&A frenzy

    Merger/Acquisition
    LAVA team collaborating and conversing in a bright, modern office space
  • NBA Europe bosses using World Cup final to hold talks with football club chiefs

    Sport Business
    Getty Images logo on a blue background, representing stock photo agency in a business news context
  • Harvey Nichols will collapse without rescue deal, directors warn

    Retail
    Exterior view of the Harvey Nichols luxury department store building facade with prominent black lettering and ornate arch...
  • Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

    Investing
    Terry Smith, founder of Fundsmith, speaking at a business conference, wearing a suit and tie, with a focused expression.
  • Richard Desmond puts £1bn Westferry development up for sale

    Property
    Richard Desmond's legal battle against Gambling Commission opened at High Court. Photo by Peter Macdiarmid/Getty Images
  • Brewdog owner shrugs off James Watt takeover bid

    Consumer
    BrewDog cans displayed in a variety of flavors and vibrant designs, highlighting the brands diverse craft beer selection.
  • James Watt eyes entire Brewdog UK business in comeback swoop

    Hospitality
    Brewdog CEO James Watt
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook